(Total Views: 535)
Posted On: 08/16/2022 4:47:53 PM
Post# of 148900
Alright last post I swear. Craig will be deleted and I will also not post about this again but for all investors I want to make this very clear.
It is up to the company to disclose any type of pertinent information from the FDA. For example like the question I brought up earlier.
The clinical hold CAN be lifted and we would not know about it until the company disclosed such information.
The company could possibly not update us on information like the clinical hold or type C meeting even though they could be completed. The FDA leaves that up to the company. Whether or not these things have been completed I have no idea.
I just want it to be clear as mud, that it is not the FDAs job to tell us a clinical hold has been lifted. It’s the companies job to do so. This is directly from a pharmacist at the FDA I spoke to on the phone and another lady I spoke to on the phone at the FDA. Feel free to call them yourself.
It is up to the company to disclose any type of pertinent information from the FDA. For example like the question I brought up earlier.
The clinical hold CAN be lifted and we would not know about it until the company disclosed such information.
The company could possibly not update us on information like the clinical hold or type C meeting even though they could be completed. The FDA leaves that up to the company. Whether or not these things have been completed I have no idea.
I just want it to be clear as mud, that it is not the FDAs job to tell us a clinical hold has been lifted. It’s the companies job to do so. This is directly from a pharmacist at the FDA I spoke to on the phone and another lady I spoke to on the phone at the FDA. Feel free to call them yourself.
(3)
(0)Scroll down for more posts ▼
